Volume 24, Issue 1, Pages (July 2016)

Slides:



Advertisements
Similar presentations
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
Advertisements

Volume 24, Issue 6, Pages (December 2016)
Volume 24, Issue 1, Pages (July 2016)
One Strike against Low-Carbohydrate Diets
Volume 10, Issue 4, Pages (October 2009)
Volume 14, Issue 2, Pages (August 2011)
Volume 15, Issue 7, Pages (May 2016)
Ghrelin—a new player in glucose homeostasis?
The Sense of Smell Impacts Metabolic Health and Obesity
Energy Sparing Orexigenic Inflammation of Obesity
Volume 15, Issue 1, Pages (January 2012)
More Than Satiety: Central Serotonin Signaling and Glucose Homeostasis
Volume 14, Issue 5, Pages (November 2013)
Volume 14, Issue 5, Pages (November 2011)
Microbial Modulation of Insulin Sensitivity
Volume 18, Issue 3, Pages (September 2013)
Volume 22, Issue 3, Pages (September 2015)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Antibiotic Exposure Promotes Fat Gain
Volume 22, Issue 2, Pages (August 2015)
Metabolic Flexibility in Health and Disease
Volume 12, Issue 6, Pages (December 2010)
Volume 143, Issue 4, Pages e7 (October 2012)
Volume 11, Issue 5, Pages (May 2010)
Volume 26, Issue 1, Pages (July 2017)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 26, Issue 4, Pages e6 (October 2017)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 6, Issue 3, Pages (September 2007)
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk  Jennifer H. Stern, Joseph M. Rutkowski,
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 26, Issue 5, Pages e3 (November 2017)
One Strike against Low-Carbohydrate Diets
Volume 24, Issue 6, Pages (December 2016)
Chad M. Trent, Martin J. Blaser  Cell Metabolism 
IL-6 Muscles In on the Gut and Pancreas to Enhance Insulin Secretion
The Stunned β Cell: A Brief History
Volume 18, Issue 5, Pages (November 2013)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 23, Issue 1, Pages e4 (January 2018)
Volume 23, Issue 6, Pages (June 2016)
Volume 21, Issue 5, Pages (May 2015)
Volume 16, Issue 3, Pages (September 2012)
Metabolic Flexibility in Health and Disease
Volume 11, Issue 3, Pages (March 2010)
Volume 10, Issue 1, Pages (July 2009)
Volume 8, Issue 4, Pages (October 2008)
Volume 9, Issue 1, Pages (January 2009)
Volume 5, Issue 5, Pages (May 2007)
Volume 24, Issue 8, Pages e7 (August 2018)
Volume 15, Issue 5, Pages (May 2012)
Volume 6, Issue 3, Pages (September 2007)
Volume 2, Issue 2, Pages (August 2005)
Volume 18, Issue 3, Pages (September 2013)
Volume 8, Issue 5, Pages (November 2008)
Sweet Mitochondrial Dynamics in VMH Neurons
Volume 14, Issue 2, Pages (August 2011)
Volume 14, Issue 6, Pages (December 2011)
Volume 6, Issue 1, Pages (July 2007)
Volume 20, Issue 4, Pages (October 2014)
Volume 24, Issue 12, Pages (September 2018)
Lipin, a lipodystrophy and obesity gene
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 4, Issue 5, Pages (November 2006)
Clémence Blouet, Hiraku Ono, Gary J. Schwartz  Cell Metabolism 
Adipose Fatty Acid Oxidation Is Required for Thermogenesis and Potentiates Oxidative Stress-Induced Inflammation  Jieun Lee, Jessica M. Ellis, Michael J.
Of Mice and Men: Not ExAKTly the Same?
Volume 26, Issue 1, Pages 1-10.e7 (January 2019)
Volume 6, Issue 6, Pages (December 2007)
Volume 4, Issue 4, Pages (October 2006)
Presentation transcript:

Volume 24, Issue 1, Pages 63-74 (July 2016) Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial  Dorien Reijnders, Gijs H. Goossens, Gerben D.A. Hermes, Evelien P.J.G. Neis, Christina M. van der Beek, Jasper Most, Jens J. Holst, Kaatje Lenaerts, Ruud S. Kootte, Max Nieuwdorp, Albert K. Groen, Steven W.M. Olde Damink, Mark V. Boekschoten, Hauke Smidt, Erwin G. Zoetendal, Cornelis H.C. Dejong, Ellen E. Blaak  Cell Metabolism  Volume 24, Issue 1, Pages 63-74 (July 2016) DOI: 10.1016/j.cmet.2016.06.016 Copyright © 2016 Elsevier Inc. Terms and Conditions

Cell Metabolism 2016 24, 63-74DOI: (10.1016/j.cmet.2016.06.016) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 The Effect of Vancomycin and Amoxicillin Treatment on Microbiota Composition Heatmap of bacterial groups (at genus and order like level with Gram staining between brackets) whose relative abundance was significantly different (q < 0.05) post-treatment within the VANCO group. Color value shows log10 fold changes compared to baseline. Genus like groups containing known butyrate producing and BA dehydroxylating species are depicted in green and red, respectively. ∗ Groups that exhibited a significant difference between VANCO and PLA treatments. See also Figure S1 and Tables S1 and S2. Cell Metabolism 2016 24, 63-74DOI: (10.1016/j.cmet.2016.06.016) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 2 The Effect of 7 Days Placebo, Amoxicillin, and Vancomycin on Hepatic, Adipose Tissue, and Peripheral Insulin Sensitivity Data are mean ± SEM (n = 56). (A) (Fasting) liver endogenous glucose production (EGP). (B) Steady-state insulin-mediated EGP suppression (%) upon 10 mU/m2/min insulin infusion. (C) Steady-state 10 mU/m2/min insulin-mediated suppression (%) of circulating FFAs as measure for adipose tissue insulin sensitivity. (D) 40 mU/m2/min insulin-stimulated glucose disposal (Rd). See also Figures S2, S5, S6 and Table S4. Cell Metabolism 2016 24, 63-74DOI: (10.1016/j.cmet.2016.06.016) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 3 The Effect of 7 Days Placebo, Amoxicillin, and Vancomycin on energy Expenditure, Substrate Metabolism, and Fecal Energy Excretion Data are mean ± SEM. Indirect calorimetry was performed during fasting conditions and for 4 hr after intake of a liquid high-fat mixed meal (HFMM) in a subgroup of n = 37. Mean O2 consumption and CO2-production over 20 min were used for calculations. (A–D) Fasting respiratory quotient (RQ), energy expenditure (EE), carbohydrate oxidation, and fat oxidation did not differ after intervention (time × treat p value > 0.05). Incremental AUCs after ingestion of HFMM were also not affected by AMOX or VANCO. (E) Fecal energy excretion (kcal/day) did not significantly change after VANCO or AMOX compared to PLA (n = 56). Cell Metabolism 2016 24, 63-74DOI: (10.1016/j.cmet.2016.06.016) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 4 The Effect of 7 Days Placebo, Amoxicillin, and Vancomycin on BA Concentrations in Plasma and Feces Data are mean ± SEM. In a subgroup of n = 37. (A) Plasma postprandial primary BA did not change significantly. (B–D) VANCO increased fecal primary BA (B), decreased plasma secondary BA (C), and fecal secondary BA (D) compared to PLA and AMOX. ∗ time × treat p value < 0.05 for VANCO versus PLA. Cell Metabolism 2016 24, 63-74DOI: (10.1016/j.cmet.2016.06.016) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 5 The Effect of 7 Days Placebo, Amoxicillin, and Vancomycin on Plasma and Fecal SCFA Concentrations (A and C–E) Data are mean ± SEM (n = 56). No significant effect was found for (A) plasma acetate, (C) plasma propionate, (D) fecal propionate, and a trend (#p = 0.07) for (E) plasma butyrate. (B and F) Fecal acetate and butyrate decreased after VANCO treatment but not after AMOX. ∗ time × treat p value < 0.05 for VANCO versus PLA and versus AMOX. Cell Metabolism 2016 24, 63-74DOI: (10.1016/j.cmet.2016.06.016) Copyright © 2016 Elsevier Inc. Terms and Conditions